![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 26, 20096-20103, June 30, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the University of Wisconsin School of Pharmacy,
Madison, Wisconsin 53706
Received for publication, March 29, 2000, and in revised form, April 25, 2000
IscS, a cysteine desulfurase implicated in the
repair of Fe-S clusters, was recently shown to act as a
sulfurtransferase in the biosynthesis of 4-thiouridine
(s4U) in tRNA (Kambampati, R., and Lauhon, C. T. (1999) Biochemistry 38, 16561-16568). In frame deletion of
the iscS gene in Escherichia coli results in a
mutant strain that lacks s4U in its tRNA. Assays of
cell-free extracts isolated from the iscS Cysteine has been shown to be the source of sulfur for the
biosynthesis of a variety of cofactors such as biotin, lipoic acid, and
thiamin (1), as well as metallosulfur clusters in proteins (2) and
thionucleotides in tRNA (3). Despite identification of the source, the
biochemical pathways for sulfur incorporation into these molecules
remain elusive. A major advance in this area was the report by Dean and
co-workers (4) that the NifS protein from Azotobacter
vinelandii is a cysteine desulfurase that is required for the
maintenance of the metallosulfur clusters in nitrogenase. A similar
enzyme in Escherichia coli, termed IscS, has been shown to
mobilize sulfur from cysteine for the repair of the [4Fe-4S] cluster
in apo-dihydroxy-acid dehydratase (5). Zheng et
al. (6) have reported that many organisms contain iscS
homologs in a gene cluster thought to be involved in the maintenance of
[Fe-S] proteins. Unsuccessful attempts to delete iscS in
A. vinelandii suggest that it is required for viability in
that organism (6).
We recently reported that in E. coli, IscS also functions as
a sulfurtransferase for the in vitro biosynthesis of
4-thiouridine in tRNA (8). Lipsett and co-workers (9-11) reported that
s4U1 was
synthesized by two factors, A and C, that were the products of the
nuvA and nuvC genes, respectively. Interestingly,
the nuvC mutant, which lacked s4U in its tRNA,
also required thiamin for growth in minimal media (12). The
thiI gene was recently identified as a requirement for both
s4U (13) and thiamin synthesis (16) in E. coli
and for thiazole biosynthesis in Salmonella typhimurium
(14).
Begley and co-workers (16) have elegantly shown that in E. coli the ultimate sulfur donor in thiamin biosynthesis is a
C-terminal thiocarboxylate of the ThiS protein. Studies with a
thiI E. coli contains three genes, including iscS,
with sequence homology to nifS. Thus, it is possible that
the in vitro activities observed for IscS are not indicative
of its role in vivo. In order to find evidence for the
in vivo relevance of iscS in s4U,
thiamin, and Fe-S cluster biosynthesis, we deleted the iscS gene in E. coli.
Strains and Plasmids--
E. coli strain MC1061 was
obtained from the E. coli Genetic Stock Center.
Electrocompetent E. coli MC1061 was obtained from Bio-Rad.
Plasmid CL010 contains the E. coli iscS gene ligated into
pET21c as described previously (8).
Media and Antibiotics--
Rich media was LB. LB/suc refers to
LB supplemented with 5% (w/v) sucrose. Minimal media were generally
M63 supplemented with glycerol (0.2% v/v) and L-leucine
(40 µg/ml), in addition to the following nutrients as required.
Thiamin, nicotinic acid, THZ, and isoleucine were used at a
concentration of 2, 50, 50, 40 µg/ml, respectively. Plasmid pKO3 and
its derivatives were propagated in LB containing chloramphenicol (20 µg/ml).
General Methods--
Plasmid DNA was isolated by the alkaline
lysis method (17). Genomic DNA was isolated using a Qiagen Genomic Tip.
Electroporation was performed with a BTX electroporator using a
protocol provided by the manufacturer specific for E. coli
MC1061. DE3 lysogens were prepared using a DE3 lysogenization kit
(Novagen). Competent cells of the DE3 lysogens were prepared by the
CaCl2 method (18). ThiI was purified from an overproducing
strain as described previously (8). Unmodified E. coli
tRNAPhe was prepared by in vitro transcription
of linearized plasmid pCF23 (8) and purified by electrophoresis on 10%
polyacrylamide, 8 M urea gel using 90 mM Tris
borate, 2 mM EDTA as running buffer.
Construction of Deletion Plasmid pID001--
Plasmid pID001
contains 1 kb of E. coli genomic DNA (500 bp each of the 5'-
and 3'-flanking region) surrounding the iscS gene. In place
of the iscS coding sequence, the plasmid contains a 33-bp tag sequence developed by the laboratory of G. M. Church for the generation of deletion strains in E. coli (19). The deletion insert was constructed essentially according to the previously reported
PCR method (19). Primers (see Table I) were chosen as suggested by
computer analysis of the E. coli genome, with the exception
of the N-terminal inside primer, Ni, which was changed to correspond to
the correct start codon, which we and others (5, 8, 21) have identified
by N-terminal sequencing of IscS. Two asymmetric PCRs using E. coli genomic DNA as a template were performed, one using the No
and Ni primers and the other using the Co and Ci primers. The
concentration of the outside primers was 0.6 µM, whereas
the inside primers were 10-fold lower in order to generate
complementary overhangs for the next reaction. After 30 cycles, 1 µl
of each reaction was combined in a single new 100-µl PCR containing
only the No and Co primers (0.6 µM each) and no
additional template DNA. After 15 additional cycles, the desired band
at 1.1 kb was purified on a 1% agarose gel followed by extraction with
a Qiaquick column (Qiagen). The resulting fragment was digested with
NotI and SalI and, after gel purification, was ligated into the NotI-SalI site of pKO3 and
transformed by electroporation into electrocompetent E. coli MC1061.
Isolation of iscS Measurement of Growth Rates--
Growth rates of wild type and
iscS Enzyme Assays--
tRNA sulfurtransferase activity for
s4U formation was measured as described previously (8). The
reaction mixture contained 50 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 50 mM KCl, 5 µg of
in vitro transcribed E. coli tRNAPhe,
5 µg of ThiI, and 63 µg of cell-free extract from either parent or
iscS HPLC Analysis of s4U in tRNA--
tRNA was analyzed
for s4U by digestion with nuclease P1 and bacterial
alkaline phosphatase essentially according to Gherke et al.
(23). Reaction mixtures containing 0.1-0.5 mg/ml tRNA, 30 mM NaOAc, pH 5.3, 0.2 mM ZnSO4, and
3 units of nuclease P1 were incubated at 37 °C for 2 h. To this
mixture 1 M Tris-HCl, pH 7.5 (4 µl for a 50-µl
reaction), was added followed by 3 units of bacterial alkaline
phosphatase and incubated for Cloning of ThiF and ThiS--
Begley and co-workers (16) have
reported the overexpression of ThiFS on a single expression plasmid and
purification of these proteins as a complex. We cloned ThiF and ThiS
separately by PCR amplification from E. coli K12 genomic
DNA. Primers for ThiF and ThiS are indicated in Table I. Each
amplification reaction (100 µl) contained 2.5 units of Pfu
polymerase (Stratagene), 0.2 mM each of dNTP, 0.5 µM each primer, and 1 µg of genomic DNA. After 30 cycles of amplification, the desired fragment was purified on a 1%
agarose gel and extracted using a Qiaquick column (Qiagen). The
purified DNA was then digested, gel-purified, and ligated into
similarly digested and dephosphorylated pET 21c (Novagen). Ligation
mixtures were transformed into NovaBlue cells for the production of
supercoiled plasmid for screening by PCR and/or sequencing. Plasmids
having the correct insert were transformed into BL21(DE3) cells for
protein expression. Cells were grown at 37 °C to an
A600 of 0.6, and IPTG was added to 0.3 mM. After 3 h, the cells were harvested by
centrifugation and lysed with lysozyme (0.3 mg/ml) in lysis buffer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 5% glycerol,
1 mM dithiothreitol, 1 mM PMSF) at 0 °C for
1 h, followed by treatment with DNase I (1 µg/g cells) for 30 min. Centrifugation at 30,000 × g for 30 min gave the
S-30 supernatant.
Purification of Overexpressed ThiF--
ThiF S-30 supernatant
(27 mg) was applied to a DEAE-Sephacel column (15-ml bed volume)
equilibrated with 50 mM Tris-HCl, pH 7.5, 50 mM
KCl, 14 mM 2-mercaptoethanol, 1 mM PMSF, 10%
glycerol. The column was washed with 30 ml of equilibration buffer, and the bound protein was eluted with a linear gradient of 50-500 mM KCl in 100 ml of equilibration buffer. Aliquots of the
fractions were electrophoresed to determine ThiF peak. DEAE eluate
(12.9 mg) was purified by gel filtration on Sephadex G-50 (225 ml bed volume) equilibrated with 50 mM Tris-HCl, pH 7.5, 200 mM KCl, 14 mM 2-mercaptoethanol, 10% glycerol,
1 mM PMSF. Pure ThiF fractions were pooled and stored at
Purification of Overexpressed ThiS--
ThiS S-30 supernatant
(23.4 mg) was applied to a DEAE-Sephacel column and eluted as described
above. The DEAE eluate (20.8 mg) was purified by gel filtration on
Sephadex G-50 as described above. Pure ThiS fractions were pooled and
concentrated using a Centricon (YM-3) centrifugal concentrator
(Millipore) and stored at In Vitro Reconstitution of ThiS Thiocarboxylation--
ThiS (176 pmol), ThiI (36 pmol), IscS (22 pmol), and ThiF (24 pmol) were
incubated together as indicated in the figure legends. Reactions were
carried in 50 µl of 50 mM Tris-HCl, pH 7.5, 10 mM Mg(OAc)2 50 mM KCl, 1 mM PMSF, 1 mM dithiothreitol, 5% glycerol, 20 µM pyridoxal phosphate, 10 µM
[35S]cysteine (4000 cpm/pmol) either in the presence or
absence of 1 mM ATP. Incubations were for 10 min at
37 °C. 0.25 volume of 5× SDS sample buffer minus 2-mercaptoethanol
was added to the assay mixtures, heated at 70 °C for 2-5 min, and
subjected to electrophoresis on SDS-15% polyacrylamide gels. Proteins
were visualized by Coomassie staining followed by phosphorimage
analysis (Molecular Dynamics).
Mass Spectrometry--
The in vitro ThiS
thiocarboxylation assay mixtures were prepared exactly as above except
unlabeled cysteine was used. After incubation, samples were loaded onto
a liquid chromatography/mass spectrometry system. HPLC was performed on
Vydac C18 column. The eluents were solvent A, 0.5% trifluoroacetic
acid in water, and solvent B, 95% CH3CN in 0.5%
trifluoroacetic acid. A linear gradient from 1 to 99% solvent B (flow
rate 20 µl/min) was used for elution. The mass spectrometer (PE Sciex
API 365) equipped with an ion spray source was used for mass detection.
Protein masses were deconvoluted using the Biospec reconstruct program.
The error in the determined mass is ±1 per 5000 atomic mass units.
Construction of the iscS
Screening potential deletion mutants by colony PCR can identify those
cells that contain the desired deletion in the genomic DNA. However, we
have found that deletion strains that grow poorly in LB/suc relative to
the parent strain will be selected against at this stage and require
the screening of many colonies before the desired mutant is found. This
was true for the iscS Growth Analysis of iscS
A significant lag phase relative to the parent strain was observed when
the iscS Complementation of the DE3 Lysogen CL100(DE3)--
Transformation
of the iscS The iscS Gene Is Required for s4U Biosynthesis in E. coli--
Extracts from the parent and iscS Purification of Overexpressed ThiF and ThiS--
Overexpressed
proteins were purified as described under "Materials and Methods."
ThiS, a small protein of 7.3 kDa, stains as a diffuse band on 15%
SDS-polyacrylamide gels (Fig. 5A,
lane 3). Although we did not determined the nucleotide sequence of plasmids, the molecular masses of purified proteins as determined by
mass spectroscopy were essentially identical to their predicted values.
Unlike the report by Begley and co-workers (16), we have not detected
complex formation between ThiF and ThiS as analyzed by native PAGE
(data not shown).
IscS Mobilizes Sulfur from Cysteine for ThiS-COSH Synthesis in
Vitro--
Begley and co-workers (16) have shown that the ultimate
sulfur donor in the biosynthesis of thiazole is ThiS-COSH. These authors reconstituted ThiS-COSH biosynthesis using ThiFSI, Mg-ATP, and
[35S]cysteine and an uncharacterized factor in E. coli crude extract (24). We attempted to reconstitute the in
vitro reaction by excluding cell extract and adding purified IscS
to the above system. Fig. 5 shows the SDS-PAGE and PhosphorImager
analysis of reactions designed to identify the requirements for
ThiS-COSH formation in vitro. Addition of IscS to ThiFS
results in the transfer of 35S from
[35S]cysteine to ThiS (Fig. 5B, lane 9). In
the absence of ATP, this sulfur transfer was reduced by more than 99%
(Fig. 5C, lane 9). This is in agreement with the report that
ThiF requires ATP for adenylation of ThiS (16). Interestingly, the
presence of ThiI is not required in our assay, although ThiI is found
to stimulate ThiS-COSH production 7-fold (Fig. 5B, lane 7).
Begley and co-workers also reported that,
in contrast to the in vivo production of ThiS-COSH, ThiI is
not required for the in vitro reaction (24), but its addition further enhances its rate. We also observed that both IscS and
ThiI are labeled with 35S during the in vitro
synthesis of ThiS-COSH (Fig. 5B, lanes 4, 7, and
9). Absence of label on ThiI alone (Fig. 5B, lane
1) indicates that IscS mobilizes 35S from
[35S]cysteine and transfers it to ThiI during ThiS-COSH
formation (Fig. 5B, lane 7). Quantitation of
35S-labeled bands (Fig. 5B) revealed that
addition of ThiI to the in vitro reaction mixture results in
the accelerated loss of 35S-label from IscS (lane
7) by 3-fold (compare lane 7 with lane 9).
This indicates that ThiI stimulates reduction of IscS persulfide. Similarly, we have previously reported (15) that addition of ThiI
increases the cysteine desulfurase activity of IscS by 2-fold.
Further evidence that IscS initiates sulfur transfer for ThiS-COSH
synthesis is provided by liquid chromatography/mass spectrometry analysis. Fig. 6A shows
unreacted ThiS with observed molecular mass of 7312 Da, which is within
instrument error (±0.02%) of the calculated mass of 7311 Da (16).
Fig. 6B shows the molecular mass of ThiS after reaction with
ThiFI, IscS, and the substrates Mg-ATP and cysteine. A relatively large
peak with mass of 7328 Da was observed, which is consistent with the
predicted mass for ThiS-COSH. However, additional peaks with mass of
7372 Da and 7448 Da were also observed. Fig. 6C shows the
same reaction in the absence of ThiI. Again a peak consistent with
ThiS-COSH (7327) is observed which is smaller than the ThiS-COSH peak
in Fig. 6B. Peaks with mass 7372 Da and 7448 Da also
decreased relative to the reaction containing ThiI (Fig.
6B). Repeating the complete reaction in the absence of
cysteine results in the observation of only the peaks with mass 7372 Da
and 7448 Da (data not shown). This suggests that these products are
formed in competition with ThiS-COSH formation and are not derived by
reaction with cysteine. At present, we have not identified these larger
mass peaks. However, the observed cysteine-dependent peak with
mass 7328 Da (Fig. 6B) and the transfer of 35S
from [35S]L-cysteine to ThiS shown in the SDS
gel analysis (Fig. 5B) provide substantial evidence that
ThiS-COSH formation is dependent on IscS.
Extracts of the parent and iscS- E. coli strains were analyzed for the ability to support ThiS-COSH
formation in the presence of all the necessary factors except IscS
(Fig. 7). As shown in Fig. 7B, 2nd
lane, the parent strain extract catalyzed efficient 35S transfer from [35S]cysteine to ThiS. The
iscS The cysteine desulfurases of the NifS family are important
candidates for sulfur mobilizers and distributors in the cell. IscS, an
NifS homolog, was initially isolated from E. coli and, like
NifS, was shown to convert cysteine into alanine and sulfane sulfur
(S0) in the form of a cysteine persulfide in its active
site (5). Since then, nifS-like genes have been found in
most organisms. Unlike prokaryotes, eukaryotes appear to contain only
one nifS gene, which in many organisms is highly homologous
to iscS. For example, the NFS1 gene of
Saccharomyces cerevisiae has 56% identity to E. coli
iscS at the amino acid level, excluding its N-terminal signal
sequence. Both the yeast and human forms are directed at least in part
to the mitochondria (27, 28), which is the location of many Fe-S
cluster-containing enzymes. NFS1 in yeast is required for
viability and was recently shown to be required for the in vivo activity of many Fe-S proteins and for the regulation of iron
transport (29). Our recent finding that IscS can provide sulfur for
s4U biosynthesis without binding to tRNA (8, 15) prompted
us to consider it for a more generalized role in sulfur metabolism. Since it has been previously shown that thiI is required for
the biosynthesis of both s4U and thiazole (13, 14, 16), we
proposed that iscS might also be required for thiazole
biosynthesis. By using an in frame gene deletion method, we have
inactivated the iscS gene within the
orf1-orf2-iscSUA-hscBA-fdx (or
isc) operon and confirm that iscS is required for
both s4U and thiazole biosynthesis in vivo.
To elucidate the biochemical step responsible for the thiamin
deficiency, we developed an in vitro assay for ThiS-COSH
biosynthesis, based on the transfer of 35S from
[35S]cysteine to ThiS. The minimal requirements for
activity are ThiF, IscS, Mg-ATP, and L-cysteine. Although
ThiI is not required in our assay, we find that it stimulates the
formation of ThiS-COSH, an effect that must be necessary for sufficient
production of ThiS-COSH in vivo. We have recently shown
evidence for the sequential transfer of S0 from IscS to
ThiI and then to tRNA during the biosynthesis of s4U (15).
Results shown in this paper suggest that a similar pathway is likely in
the biosynthesis of ThiS-COSH. However, there are significant
differences between the two reactions. ThiS-COSH synthesis requires
adenylation by ThiF (16), and ThiI appears to act solely as a
sulfurtransferase. Alternatively, in s4U synthesis, ThiI
accepts sulfur from IscS and also likely activates the uridine on the
tRNA using Mg-ATP and transfers the sulfur to give s4U. We
have found no evidence for the stimulation of s4U
biosynthesis by ThiF nor have we observed transfer of 35S
to ThiF during ThiS-COSH synthesis. It is possible that a
sulfur-modified ThiF is a metastable intermediate under the assay
conditions and is merely not observed; however, the results thus far
suggest that ThiI is the ultimate sulfurtransferase for both
s4U and ThiS-COSH synthesis.
For the two pathways (Fig. 8), the
initial step is the mobilization of sulfur from L-cysteine
by IscS, resulting in the formation of an IscS-derived cysteine
persulfide (IscS-SSH). This S0 is transferred from IscS-SSH
to ThiI to give a putative ThiI persulfide (ThiI-SSH). Sulfur is then
mobilized from ThiI-SSH and subsequently transferred to the activated
uridine or ThiS adenylate (ThiS-COAMP) to give the product. We have
found that IscS/cysteine can be replaced by millimolar concentrations
of inorganic sulfide (data not shown). This suggests the possibility that nascent sulfide is produced in the ThiI-active site for addition to an enzyme-bound activated intermediate. We have previously shown
that the thiol-specific alkylating agent
5-((2-iodoacetamido)ethyl)-1-aminonapthalene sulfonic acid can abolish
the tRNA sulfurtransferase activity of ThiI (15). Thus, one or more of
the cysteine residues in ThiI is required for s4U
synthesis, which is consistent with the mechanism outlined in Fig. 8.
Flint (5) initially proposed that IscS may donate S0 to a
variety of protein acceptors for the synthesis of Fe-S clusters. It now
appears that IscS provides S0 for the incorporation of
sulfur into a variety of substrates, in addition to Fe-S clusters.
The iscS Gene in Escherichia coli Is
Required for the Biosynthesis of 4-Thiouridine, Thiamin, and NAD*
and
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
strain confirm the complete loss of tRNA sulfurtransferase activity. In
addition to lacking s4U, the iscS
strain requires thiamin and nicotinic acid for growth in minimal media.
The thiamin requirement can be relieved by the addition of the thiamin
precursor 5-hydroxyethyl-4-methylthiazole, indicating that
iscS is required specifically for thiazole biosynthesis. The growth rate of the iscS
strain is half
that of the parent strain in rich medium. When the
iscS
strain is switched from rich to minimal
medium containing thiamin and nicotinate, growth is preceded by a
considerable lag period relative to the parent strain. Addition of
isoleucine results in a significant reduction in the duration of this
lag phase. To examine the thiazole requirement, we have reconstituted
the in vitro biosynthesis of ThiS thiocarboxylate, the
ultimate sulfur donor in thiazole biosynthesis, and we show that IscS
mobilizes sulfur for transfer to the C-terminal carboxylate of ThiS.
ThiI, a known factor involved in both thiazole and s4U
synthesis, stimulates this sulfur transfer step by 7-fold. Extracts from the iscS
strain show significantly
reduced activity in the in vitro synthesis of ThiS
thiocarboxylate. Transformation of the iscS
strain with an iscS expression plasmid complemented all of
the observed phenotypic effects of the deletion mutant. Of the
remaining two nifS-like genes in E. coli,
neither can complement loss of iscS when each is
overexpressed in the iscS
strain. Thus, IscS
plays a significant and specific role at the top of a potentially broad
sulfur transfer cascade that is required for the biosynthesis of
thiamin, NAD, Fe-S clusters, and thionucleosides.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
strain revealed that thiI is
required for ThiS-COSH synthesis in vivo (16). The shared
pathway for s4U and thiamin biosynthesis suggested that
ThiI was a sulfurtransferase. However, the factor that initiates the
mobilization of sulfur from cysteine for ThiS-COSH synthesis remained
unknown (7). Our finding that IscS was able to complete s4U
biosynthesis in vitro (outlined in Fig.
1) suggested that it might also function
to initiate sulfur transfer in the synthesis of ThiS-COSH. In the
present study we have reconstituted ThiS thiocarboxylate formation, and
we demonstrate that IscS can indeed provide sulfur in vitro
for the synthesis of ThiS-COSH.

View larger version (12K):
[in a new window]
Fig. 1.
Factors required for the biosynthesis of
s4U and ThiS-COSH in E. coli.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Strain--
A combination of the
methods described by Kushner and co-workers (22) and Church and
co-workers (19) was used to facilitate isolation of mutant strains that
grow very poorly in rich media. After electroporation of plasmid pID001
(Table I) into E. coli MC1061, the cells (60 µl) were
diluted with 1 ml of SOC medium and allowed to recover with shaking at
30 °C for 1 h. A total of 900 µl of the cells were plated
onto 5 LB/cam plates prewarmed to 43 °C, and 10 and 50 µl,
respectively, were plated onto two LB/cam plates at 30 °C. Two
cointegrate colonies were observed on the 43 °C plates, whereas many
colonies appeared on the 30 °C plates. The integration frequency was
estimated to be 10
5. The two cointegrate
colonies were propagated separately in LB/cam for 3 days, by diluting
daily into fresh media. The final saturated cultures were serially
diluted (10
6) and plated onto LB/cam plates
at 30 °C to isolate resolved cointegrates. Plasmid DNA was isolated
from overnight cultures of a master plate of 20 clones, and 4 were
found to have the wild type gene on the plasmid, indicating a possible
gene replacement event. Two of these colonies were then picked
separately into 3 ml of LB, serially diluted
(10
4) and plated onto LB/suc plates for
plasmid release. A master plate of the LB/suc colonies was
replica-plated onto an LB/cam plate to identify colonies that had lost
plasmid and were chloramphenicol-sensitive (CmS). Several
CmS colonies were then grown overnight in 3 ml of LB for
isolation of genomic DNA. PCR analysis of the genomic DNA was performed using primers that flanked the iscS gene.
strains were measured as follows. A
single colony of either the wild type or iscS
strains was grown in 3 ml of LB to saturation. A 200-fold dilution was
then made into 100 ml of LB, and cell density was monitored by
absorbance at 595 nm. Growth in minimal media was measured in the same
manner as above. Growth measurements when switching from rich to
minimal media were made by diluting saturated cultures of either the
parent or iscS
strains grown in LB medium into
minimal medium containing additives as indicated.
strain.
1 h. Approximately 10 µg of digested
tRNA was loaded on a reverse phase HPLC column (Supelco LC-18S) and
eluted with a linear gradient (60 min) of 0.5-20% methanol in 10 mM ammonium phosphate, pH 5.3. Peaks were detected at 330 nm, which is specific for the absorbance of s4U.
80 °C until use.
80 °C.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Strain--
We used a
method for the precise in frame deletion of E. coli genes
that was originally developed by Kushner and co-workers (22) and
recently modified by Church and co-workers (19). The deletion insert
was constructed using a two-step PCR method, which replaces the coding
sequence of iscS with a 33-bp sequence (Table
I) that codes for an innocuous peptide
(19). This in frame insert is designed to prevent polar effects on
downstream genes within the same operon. This concern is applicable to
iscS since it is known to be located in a multicistronic
operon (6). The iscS deletion construct was ligated into
plasmid pKO3 (19), which contains a temperature-sensitive origin of
replication that allows the selection of cells with plasmid integrated
into the genome (cointegrates) at the nonpermissible temperature
(43 °C) in the presence of chloramphenicol. Growth of isolated
cointegrates at the permissible temperature (30 °C) in the presence
of antibiotic gives resolved cointegrates, in which the plasmid has
been excised from the genome. Plasmid pKO3 also contains the
Bacillus subtilis sacB gene for levansucrase. This gene is
deleterious for growth in E. coli in the presence of high
sucrose concentrations. Thus, it is possible to select for cells that
have both resolved and released the plasmid from their genomic DNA by
plating cointegrates on LB/suc plates at 30 °C. Replica plating from
the LB/suc plate onto LB/cam plates will identify those colonies that
grow in the presence of sucrose, but are chloramphenicol-sensitive, and
have thus released the plasmid.
Strains, plasmids, and primers used in this work
strain, which grows
relatively slowly in rich medium. We found it more convenient to
resolve the cointegrates using Kushner's original procedure by
propagation at 30 °C for several days in LB/cam and then plating and
screening the plasmid DNA of individual colonies for the presence of
the wild type gene. Such cells should have the desired deletion in
their genomic DNA because of the double crossover event. Dilution and
plating these candidates onto LB/suc then gives a large proportion
(>50%) of the desired deletion mutants free of plasmid DNA. For
iscS
strains, such colonies required an
additional 12-16 h to appear on the LB/suc plates. As shown in Fig.
2, we verified the gene deletion by PCR
analysis of genomic DNA with primers flanking the iscS gene.
Lane 2 shows the expected 2.2-kb PCR product of the parent
strain MC1061 genomic DNA, and lane 3 shows the expected smaller 1.1-kb product for the iscS deletion strain (CL100).
In addition, complementation with wild type iscS (see below)
gave a phenotype that was indistinguishable from the parent strain.

View larger version (14K):
[in a new window]
Fig. 2.
PCR analysis of genomic DNA in parent strain
MC1061 and iscS deletion strain CL100. Lane
M, kilobase molecular weight markers; lane 1, no
template (negative control); lane 2, MC1061 DNA with No and
Co primers; lane 3, iscS
DNA with
No and Co primers.
Strain CL100--
Fig.
3A shows the growth of the
iscS
and E. coli parent strains in
LB medium at 37 °C. The iscS
strain was
significantly growth-impaired in rich medium. The doubling time of the
iscS
strain is 55 min, which is 2-fold greater
than that of the parent strain (27 min). The
iscS
strain did not grow in M9/glucose or
M63/glycerol minimal media supplemented with leucine (parent strain
MC1061 is a leucine auxotroph). Because of earlier reports (12-14) on
the relationship between s4U and thiamin biosynthesis and
our recent work, we suspected that thiamin was also necessary for
growth. However, addition of thiamin to the minimal medium was
insufficient for growth. Only after combined addition of nicotinic acid
and thiamin was growth observed.

View larger version (12K):
[in a new window]
Fig. 3.
Relative growth of parent (MC1061) and
iscS
strains. A, growth
of MC1061 and two iscS
strains, CL100 and
CL115, in LB at 37 °C. B, growth of parent and deletion
strains after dilution of saturated LB culture into
M63/glycerol/leucine with the following additives:
, MC1061 without
additives;
, CL100 with thi and nic;,
, CL100 with thi, nic, and
Ile;
, CL100 of MC1061 with thi, nic, Ile, and Val.
strain was switched from rich to
minimal medium containing thiamin and nicotinate. Flint (5) has
reported that IscS can repair the Fe-S clusters of apo-dihydroxy-acid
dehydratase, an enzyme required for the biosynthesis of isoleucine and
valine. Therefore, we measured the duration of the lag phase in the
presence of these amino acids. Fig. 3B shows that the lag
time relative to the parent strain is substantially reduced in the
presence of isoleucine and is reduced further in the presence of both
isoleucine and valine. This effect suggests that an enzyme involved in
isoleucine/valine biosynthesis, possibly dihydroxy-acid dehydratase, is
defective in the iscS
strain. No other amino
acid had any observable effect. Interestingly, the exponential rates of
growth are the same for both parent and mutant strains under all
minimal medium conditions tested; however, it should be noted that this
is a much slower rate of growth than in rich medium.
DE3 lysogen CL100(D3) with a
pET-derived IscS expression plasmid, pCL010 (see Table I), resulted in
complementation of all of the observed phenotypic effects of iscS deletion. The growth rate of CL100(DE3)/pCL010 was
equal to the parent MC1061 in rich medium in the presence or absence of
IPTG, indicating that the uninduced expression of iscS in
the lysogen is significant. SDS gel analysis of cell extracts from the
iscS
strain grown in the presence of IPTG
shows a large band at the correct relative mass of IscS (data not
shown). CL100 was also fully complemented by a derivative of pKO3 that
contains the E. coli iscS gene with the same flanking 500-bp
regions as in the deletion construct.
strains were assayed for tRNA sulfurtransferase activity. The
iscS
extract contained significantly reduced
activity (2.6% of parent strain extract). tRNA isolated from the
iscS
strain grown in LB was analyzed for the
presence of s4U. The UV-visible spectra of tRNA from
E. coli MC1061 (parent strain) shows a characteristic peak
due to absorbance of s4U at 330-340 nm, whereas for the
CL100 tRNA there is no evidence of a peak in this region.
Complementation with pCL010, which contains wild type iscS,
restores the absorbance in this region of the tRNA spectrum (data not
shown). To confirm further the presence or absence of s4U,
unfractionated tRNA isolated from each strain was digested to
nucleosides as described (23). HPLC analysis of the tRNA digests (Fig.
4) shows clearly that the
iscS
strain is completely devoid of
s4U (Fig. 4B). As predicted, tRNA from the
complemented strain CL100(DE3)/pCL010 shows a peak for s4U
in the chromatogram that is similar in magnitude to that of the parent
strain (Fig. 4C). These results show conclusively that iscS is required for the biosynthesis of s4U
in vivo.

View larger version (5K):
[in a new window]
Fig. 4.
HPLC analysis of the tRNA isolated from the
iscS
mutant and the
iscS
mutant complemented with IscS.
A-D represent chromatograms of tRNA digests from E. coli parent strain (MC1061), iscS
mutant,
iscS
mutant transformed with pCL010 (wild type
iscS), and parent strain + standard s4U,
respectively.

View larger version (59K):
[in a new window]
Fig. 5.
In vitro thiocarboxylation of
ThiS. Reactions were carried as described under "Materials and
Methods." Lanes 1-4, ThiI, ThiF, ThiS, and IscS
respectively; lane 5, ThiFS; lane 6, ThiFSI;
lane 7, ThiFSI + IscS; lane 8, ThiS + IscS,
lane 9, ThiFS + IscS; lane 10, ThiSI.
A is Coomassie-stained gel. B and C
show the phosphorimage scans of reactions performed in the presence and
absence of ATP, respectively.

View larger version (16K):
[in a new window]
Fig. 6.
Characterization of ThiS-COSH by mass
spectrometry. ThiFSI, IscS, Mg-ATP, and cysteine were incubated
together in buffer and analyzed by liquid chromatography/mass
spectrometry as described under "Materials and Methods." Only the
mass region of ThiS is shown here. A, mass spectrum of ThiS
alone. B and C show the mass spectrum of ThiS
incubated with ATP and cysteine in the presence and absence of ThiI,
respectively.
strain showed significantly reduced
sulfurtransferase activity (Fig. 7B, 4th lane). Quantitation
of the 35S-labeled ThiS-COSH band formed by the
iscS
cell extract gave a value of 16% that of
wild type.

View larger version (51K):
[in a new window]
Fig. 7.
Effect of iscS deletion on
the in vitro thiocarboxylation of ThiS. S-30
supernatant (23.2 µg) from either wild type or
iscS
mutant was incubated with purified ThiFSI
and [35S]cysteine and subjected to SDS-PAGE (15%
polyacrylamide) and PhosphorImager analysis as described under
"Materials and Methods." A and B represent
Coomassie-stained gel and its phosphorimage, respectively.
Wt, wild type.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (15K):
[in a new window]
Fig. 8.
Overview of the mobilization and scope of
distribution of sulfur by E. coli IscS. The
dashed arrows indicate interactions that are proposed or for
which evidence is found in vitro.
Although the iscS
strain shows significantly
impaired growth relative to the parent strain in rich medium, we have
found that the two strains have identical exponential growth rates in
minimal medium. This is likely due to the much longer doubling time
(180 min) observed for each strain in either M9/glucose or M63/glycerol medium supplemented with leucine. It is likely that the activity of the enzymes affected by the iscS deletion is sufficient
for the lower growth rate but becomes rate-limiting during faster growth in rich medium. A similar effect was recently observed for an
E. coli tufA
strain (20).
The growth delay observed when the iscS
strain
was switched from rich to minimal medium was largely alleviated by the
addition of isoleucine and, to a lesser extent, valine. From earlier
published work (5), we suspect that a partial explanation for the
growth delay is a deficiency in the formation of Fe-S clusters in the Ile/Val pathway enzyme dihydroxy-acid dehydratase. We are currently attempting to confirm this experimentally. Since the growth delay is
not completely alleviated with Ile/Val, there are likely other pathways
affected. A gene expression analysis of the isc gene cluster
also suggests that iscS is involved in the synthesis of a
wide variety of Fe-S proteins (39). In addition, it has been recently
reported that inactivation of iscS affected Fe-S cluster assembly in ferredoxins (36).
The iscS
strain also requires nicotinic acid
for growth in minimal medium. This requirement has precedence, since in
B. subtilis, an nifS gene is required for the
biosynthesis of NAD (30). The proposed target of the nicotinate
deficiency is quinolinate synthetase (NadA), one component of a system
that condenses L-aspartate and dihydroxyacetone phosphate
to give quinolinate (30). Interestingly, this enzyme and dihydroxy-acid
dehydratase are both Fe-S enzymes known to be inactivated by hyperbaric
oxygen (31, 32).
E. coli contains three genes with homology to
nifS. In addition to iscS, these are
cysteine-sulfinate desulfinase (33) and csdB (34). The
csdB gene is identical to sufS, which was found to be required for the stable maintenance of the [2Fe-2S]-containing Fhuf protein in E. coli (35). Each of the three proteins has been purified and shown to catalyze the desulfuration of cysteine and
the deselenation of selenocysteine with varying efficiency. CsdB shows
significant selectivity for selenocysteine, and the recently reported
crystal structure (36) reveals fundamental differences in structure
compared with that predicted for IscS. Cysteine-sulfinate desulfinase
and CsdB (SufS) have been grouped separately from IscS based on amino
acid sequence homology (33). We have found no obvious phenotype for
deletion of cysteine-sulfinate desulfinase or
csdB,3 although it
has been reported that sufS mutants cannot utilize ferrioxamine B as an iron source (35). In addition, the overexpression of either cysteine-sulfinate desulfinase or CsdB in an
iscS
strain, CL100(DE3), does not complement
any observed characteristics of the iscS
phenotype.4 This may not be
surprising for CsdB, in light of its unique structure and substrate specificity.
Fig. 8 shows a summary of the proposed role for IscS in the
biosynthesis of sulfur-containing metabolites. It is possible that the
distribution of sulfur in all of these cases involves the transfer of
S0 to a distinct protein acceptor. In the case of tRNA
thionucleoside biosynthesis, additional potential sulfur acceptors have
already been identified. These include TrmU, which is required for the biosynthesis of 2-thiouridine derivatives (37), and MiaB, which is
required for the synthesis of the 2-methylthio group in
ms2i6A (38). We are currently investigating the
potential role of iscS in the biosynthesis of each of these
modified bases. Future studies are directed at further elucidation of
the scope of iscS-initiated sulfur transfer as well as the
mechanism of the transfer itself.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Amy Harms, Biotechnology Center, University of Wisconsin, Madison, for mass spectrometric analysis. We also thank Diana Downs and Patricia Kiley for communication of results prior to publication.
| |
Addendum |
|---|
After submission of this paper Palenchar et al. (26) showed that mutation of Cys-456 of ThiI impairs tRNA sulfurtransferase activity and the synthesis of s4U in vivo. We have also recently learned of two other groups that have isolated iscS mutants and report findings that are comparable with our results.5
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant GM57002 and a grant from the University of Wisconsin Graduate School.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: University of
Wisconsin School of Pharmacy, 425 N. Charter St., Madison, WI 53706. Tel.: 608-262-3083; Fax: 608-262-3397; E-mail:
clauhon@facstaff.wisc.edu.
Published, JBC Papers in Press, April 25, 2000, DOI 10.1074/jbc.M002680200
2 T. P. Begley, Xi, J., Kinsland, C., Taylor, S., and Mclafferty, F., unpublished data.
3 C. T. Lauhon and A. Bednar, unpublished observations.
4 C. T. Lauhon, unpublished observations.
5 P. Kiley and D. Downs, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
s4U, 4-thiouridine;
ThiS-COSH, ThiS thiocarboxylate;
S0, sulfane
sulfur;
PAGE, polyacrylamide gel electrophoresis;
kb, kilobase pair;
PCR, polymerase chain reaction;
PMSF, phenylmethylsulfonyl fluoride;
HPLC, high pressure liquid chromatography;
bp, base pair;
IPTG, isopropyl-1-thio-
-D-galactopyranoside.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Begley, T. P., Xi, J., Kinsland, C., Taylor, S., and McLafferty, F. (1999) Curr. Opin. Chem. Biol. 3, 623-629 |
| 2. | Sticht, H., and Rosch, P. (1998) Prog. Biophys. Mol. Biol. 70, 95-136 |
| 3. | Ajitkumar, P., and Cherayil, J. D. (1988) Microbiol. Rev. 52, 103-113 |
| 4. | Zheng, L., White, R. H., Cash, V. L., Jack, R. F., and Dean, D. R. (1993) Proc. Nat. Acad. Sci. U. S. A. 90, 2754-2758 |
| 5. | Flint, D. H. (1996) J. Biol. Chem. 271, 16068-16074 |
| 6. | Zheng, L., Cash, V. L., Flint, D. H., and Dean, D. R. (1998) J. Biol. Chem. 273, 13264-13272 |
| 7. | Deleted in proof |
| 8. | Kambampati, R., and Lauhon, C. T. (1999) Biochemistry 38, 16561-16568 |
| 9. | Lipsett, M. N. (1972) J. Biol. Chem. 247, 1458-1461 |
| 10. | Abrell, J. W., Kaufman, E. E., and Lipsett, M. N. (1971) J. Biol. Chem. 246, 294-301 |
| 11. | Lipsett, M. N. (1978) J. Bacteriol. 135, 993-997 |
| 12. | Ryals, J., Hsu, R.-Y., Lipsett, M. N., and Bremer, H. (1982) J. Bacteriol. 151, 899-904 |
| 13. | Mueller, E. G., Buck, C. J., Palenchar, P. M., Barnhart, L. E., and Paulson, J. L. (1998) Nucleic Acids Res. 26, 2606-2610 |
| 14. | Webb, E., Class, K., and Downs, D. M. (1997) J. Bacteriol. 179, 4399-4402 |
| 15. | Kambampati, R., and Lauhon, C. T. (2000) J. Biol. Chem. 275, 10727-10730 |
| 16. | Taylor, S. V., Kelleher, N. L., Kinsland, C., Chiu, H.-J., Costello, C. A., Backstrom, A. D., McLafferty, F. W., and Begley, T. P. (1998) J. Biol. Chem. 273, 16555-16560 |
| 17. | Birnboim, H. C., and Doly, J. (1979) Nucleic Acids Res. 7, 1513-1523 |
| 18. | Petes, T. D., Broach, J. R., Wensink, P. C., Hereford, L. M., Fink, G. R., and Botstein, D. (1978) Gene (Amst.) 4, 37-49 |
| 19. | Link, A. J., Phillips, D., and Church, G. M. (1997) J. Bacteriol. 179, 6228-6237 |
| 20. | Zuurmond, A. M., Rundlof, A. K., and Kraal, B. (1999) Mol. Gen. Genet. 260, 603-607 |
| 21. | Link, A. J., Robison, K., and Church, G. M. (1997) Electrophoresis 18, 1259-1313 |
| 22. | Hamilton, C. M., Aldea, M., Washburn, B. K., Babitzke, P., and Kushner, S. R. (1989) J. Bacteriol. 171, 4617-4622 |
| 23. | Gehrke, C. W., Kuo, K. C., McCune, R. A., and Gerhardt, K. O. (1982) J. Chromatogr. 230, 297-308 |
| 24. | Begley, T. P., Downs, D. M., Ealick, S. E., McLafferty, F. W., Van Loon, A. P. G. M., Taylor, S., Campobasso, N., Chiu, H. J., Kinsland, C., Reddick, J. J., and Xi, J. (1999) Arch. Microbiol. 171, 293-300 |
| 25. | Jacobsen, M. R., Cash, V. L., Weiss, M. C., Laird, N. F., Newton, W. E., and Dean, D. R. (1989) Mol. Gen. Genet. 219, 49-57 |
| 26. | Palenchar, P. M., Buck, C. J., Cheng, H., Larson, T. J., and Mueller, E. G. (2000) J. Biol. Chem. 275, 8283-8286 |
| 27. | Kispal, G., Csere, P., Prohl, C., and Lill, R. (1999) EMBO J. 18, 3981-3999 |
| 28. | Land, T., and Rouault, T. A. (1998) Mol. Cell. 2, 807-815 |
| 29. | Li, J., Kogan, M., Knight, S. A. B., Pain, D., and Dancis, A. (1999) J. Biol. Chem. 274, 33025-33034 |
| 30. | Sun, D., and Setlow, P. (1993) J. Bacteriol. 175, 1423-1432 |
| 31. | Draczynska-Lusiak, B., and Brown, O. R. (1992) Free Radic. Biol. Med. 13, 689-693 |
| 32. | Brown, O. R., and Yein, F. (1978) Biochem. Biophys. Res. Commun. 85, 1219-1224 |
| 33. | Mihara, H., Kurihara, T., Yoshimura, T., Soda, K., and Esaki, N. (1997) J. Biol. Chem. 272, 22417-22424 |
| 34. | Mihara, H., Maeda, M., Fujii, T., Kurihara, T., Hata, Y., and Esaki, N. (1999) J. Biol. Chem. 274, 14768-14772 |
| 35. | Patzer, S. I., and Hantke, K. (1999) J. Bacteriol. 181, 3307-3309 |
| 36. | Fujii, T., Maeda, M., Mihara, H., Kurihara, T., Esaki, N., and Hata, Y. (2000) Biochemistry 39, 1263-1273 |
| 37. | Sullivan, M. A., Cannon, J. F., Webb, F. H., and Bock, R. M. (1985) J. Bacteriol. 161, 368-376 |
| 38. | Esberg, B., Leung, H. C. E., Tsui, H. C. T., Bjork, G. R., and Winkler, M. E (1999) J. Bacteriol. 181, 7256-7265 |
| 39. | Nakamura, M., Saeki, K., and Takahashi, Y. (1999) J. Biochem. (Tokyo) 126, 10-18 |
This article has been cited by other articles:
![]() |
Y. Nakai, M. Nakai, and H. Hayashi Thio-modification of Yeast Cytosolic tRNA Requires a Ubiquitin-related System That Resembles Bacterial Sulfur Transfer Systems J. Biol. Chem., October 10, 2008; 283(41): 27469 - 27476. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Marelja, W. Stocklein, M. Nimtz, and S. Leimkuhler A Novel Role for Human Nfs1 in the Cytoplasm: Nfs1 ACTS AS A SULFUR DONOR FOR MOCS3, A PROTEIN INVOLVED IN MOLYBDENUM COFACTOR BIOSYNTHESIS J. Biol. Chem., September 12, 2008; 283(37): 25178 - 25185. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ayala-Castro, A. Saini, and F. W. Outten Fe-S Cluster Assembly Pathways in Bacteria Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 110 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakai, M. Nakai, R. Lill, T. Suzuki, and H. Hayashi Thio Modification of Yeast Cytosolic tRNA Is an Iron-Sulfur Protein-Dependent Pathway Mol. Cell. Biol., April 15, 2007; 27(8): 2841 - 2847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Neumann, M. Schulte, N. Junemann, W. Stocklein, and S. Leimkuhler Rhodobacter capsulatus XdhC Is Involved in Molybdenum Cofactor Binding and Insertion into Xanthine Dehydrogenase J. Biol. Chem., June 9, 2006; 281(23): 15701 - 15708. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shigi, Y. Sakaguchi, T. Suzuki, and K. Watanabe Identification of Two tRNA Thiolation Genes Required for Cell Growth at Extremely High Temperatures J. Biol. Chem., May 19, 2006; 281(20): 14296 - 14306. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Lundgren and G. R. Bjork Structural Alterations of the Cysteine Desulfurase IscS of Salmonella enterica Serovar Typhimurium Reveal Substrate Specificity of IscS in tRNA Thiolation. J. Bacteriol., April 1, 2006; 188(8): 3052 - 3062. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Loiseau, S. Ollagnier-de Choudens, D. Lascoux, E. Forest, M. Fontecave, and F. Barras Analysis of the Heteromeric CsdA-CsdE Cysteine Desulfurase, Assisting Fe-S Cluster Biogenesis in Escherichia coli J. Biol. Chem., July 22, 2005; 280(29): 26760 - 26769. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Heidenreich, S. Wollers, R. R. Mendel, and F. Bittner Characterization of the NifS-like Domain of ABA3 from Arabidopsis thaliana Provides Insight into the Mechanism of Molybdenum Cofactor Sulfuration J. Biol. Chem., February 11, 2005; 280(6): 4213 - 4218. [Abstract] [Full Text] [PDF] |
||||
![]() |
|